DataKnowledgeCloudtrainingcoordination

Familial hypercholesterolemia - heterozygous (Disease Or Phenotype)

Medcin:MEDCIN:38627

Mdr:MDR:10057079

Id:4caa667a-5a0a-54bf-8d15-c77d07b13a5f

Results found

Linked to

	Label	Description
	Choline fenofibrate indication Familial hypercholesterolemia - heterozygous Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	ezetimibe indication Familial hypercholesterolemia - heterozygous Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cemdisiran indication Familial hypercholesterolemia - heterozygous Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(E)-(3R,5S)-7-[4-(4-Fluoro-phenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid anion indication Familial hypercholesterolemia - heterozygous Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	fenofibrate indication Familial hypercholesterolemia - heterozygous Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	monacolin K indication Familial hypercholesterolemia - heterozygous Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	atorvastatin indication Familial hypercholesterolemia - heterozygous Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Pravastatin indication Familial hypercholesterolemia - heterozygous Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	simvastatin indication Familial hypercholesterolemia - heterozygous Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Fluvastatin sodium indication Familial hypercholesterolemia - heterozygous Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Choline fenofibrate indication Familial hypercholesterolemia - heterozygous

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

ezetimibe indication Familial hypercholesterolemia - heterozygous

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Cemdisiran indication Familial hypercholesterolemia - heterozygous

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(E)-(3R,5S)-7-[4-(4-Fluoro-phenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid anion indication Familial hypercholesterolemia - heterozygous

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

fenofibrate indication Familial hypercholesterolemia - heterozygous

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

monacolin K indication Familial hypercholesterolemia - heterozygous

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

atorvastatin indication Familial hypercholesterolemia - heterozygous

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Pravastatin indication Familial hypercholesterolemia - heterozygous

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

simvastatin indication Familial hypercholesterolemia - heterozygous

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Fluvastatin sodium indication Familial hypercholesterolemia - heterozygous

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.